CERo Therapeutics Holdings, Inc.

NASDAQ (USD): CERo Therapeutics Holdings, Inc. (CERO)

Last Price

0.068

Today's Change

+0.006 (9.83%)

Day's Change

0.066 - 0.087

Trading Volume

141,918,721

Profile
CERO

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Christopher B. Ehrlich M.B.A. Mr. Christopher B. Ehrlich M.B.A.

Full Time Employees:  8 8

IPO Date:  2021-11-30 2021-11-30

CIK:  0001870404 0001870404

ISIN:  US71902K1051 US71902K1051

CUSIP: 

Beta:  -0.46 -0.46

Last Dividend:  0.00 0.00

Dcf Diff:  0.45 0.45

Dcf:  -0.22 -0.22

Description

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Address

201 Haskins Way,
South San Francisco, CA 94080, US

650-407-2376

http://www.cero.bio

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment